Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 102,316 | 100,497 | 102,953 | 125,158 | 135,821 |
| Marketable Securities | 272,327 | 275,764 | 284,723 | 268,984 | 252,443 |
| Receivables | 47,101 | 42,753 | 41,864 | 36,713 | 34,155 |
| Inventories | 1,726 | 1,614 | 1,469 | 1,505 | 1,357 |
| TOTAL | $438,890 | $432,387 | $439,180 | $439,425 | $432,946 |
| Non-Current Assets | |||||
| PPE Net | 2,132 | 2,178 | 2,303 | 2,306 | 2,037 |
| Intangibles | 114,096 | 115,848 | 117,599 | 119,351 | 121,369 |
| Other Non-Current Assets | 101,086 | 94,702 | 92,289 | 91,600 | 92,088 |
| TOTAL | $217,314 | $212,728 | $212,191 | $213,257 | $215,494 |
| Total Assets | $656,204 | $645,115 | $651,371 | $652,682 | $648,440 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 39,086 | 39,304 | 39,598 | 37,773 | 38,460 |
| Other current liabilities | 60,895 | 49,786 | 54,193 | 55,569 | 49,237 |
| TOTAL | $99,981 | $89,090 | $93,791 | $93,342 | $87,697 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 14,531 | 14,802 | 15,064 | 15,345 | 15,833 |
| TOTAL | $17,677 | $14,802 | $15,064 | $15,345 | $15,833 |
| Total Liabilities | $117,658 | $103,892 | $108,855 | $108,687 | $103,530 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,316 | 58,308 | 58,290 | 58,198 | 57,538 |
| Common Shares | 58 | 58 | 58 | 58 | 58 |
| Retained earnings | -174,292 | -169,380 | -164,056 | -159,538 | -155,392 |
| Other shareholders' equity | 74 | 702 | -330 | -383 | -30 |
| TOTAL | $538,546 | $541,223 | $542,516 | $543,995 | $544,910 |
| Total Liabilities And Equity | $656,204 | $645,115 | $651,371 | $652,682 | $648,440 |